LGT Vestra LLP Form 8.3 - Primary Health Properties plc (2260S)
08 3월 2019 - 1:23AM
UK Regulatory
TIDMPHP
RNS Number : 2260S
LGT Vestra LLP
07 March 2019
NOTE: Most up to date disclosure - replaces RNS Number 0559S
FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1%
OR MORE
Rule 8.3 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Full name of discloser: LGT Vestra LLP
(b) Owner or controller of interests and short positions n/a
disclosed, if different from 1(a):
The naming of nominee or vehicle companies is
insufficient. For a trust, the trustee(s),
settlor and beneficiaries must be named.
----------------------------------------------------------
(c) Name of offeror/offeree in relation to whose relevant Primary Health Properties plc (offeror)
securities this form relates:
Use a separate form for each offeror/offeree
----------------------------------------------------------
(d) If an exempt fund manager connected with an n/a
offeror/offeree, state this and specify identity
of offeror/offeree:
----------------------------------------------------------
(e) Date position held/dealing undertaken: 05/03/2019 (see table at the bottom of the document for
For an opening position disclosure, state the latest previously undisclosed trades executed)
practicable date prior to the disclosure
----------------------------------------------------------
(f) In addition to the company in 1(c) above, is the No
discloser making disclosures in respect
of any other party to the offer?
If it is a cash offer or possible cash offer, state "N/A"
----------------------------------------------------------
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
If there are positions or rights to subscribe to disclose in
more than one class of relevant securities of the offeror or
offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for
each additional class of relevant security.
(a) Interests and short positions in the relevant securities of
the offeror or offeree to which the disclosure relates following
the dealing (if any)
Class of relevant security: 12.5p Ordinary
Interests Short positions
------------------ ------------------
Number % Number %
----------- ----- ------------- ---
(1) Relevant securities owned and/or controlled: 11,464,260 1.40
----------- ----- ------------- ---
(2) Cash-settled derivatives: n/a n/a
----------- ----- ------------- ---
(3) Stock-settled derivatives (including options) and agreements to n/a n/a
purchase/sell:
----------- ----- ------------- ---
TOTAL: 11,464,260 1.40
----------- ----- ------------- ---
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions
(including traded options), or agreements to purchase or sell
relevant securities, should be given on a Supplemental Form 8 (Open
Positions).
(b) Rights to subscribe for new securities (including directors' and other employee options)
Class of relevant security in relation to which subscription right exists: 12.5p ordinary
Details, including nature of the rights concerned and relevant percentages: Ordinary rights
----------------
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
Where there have been dealings in more than one class of
relevant securities of the offeror or offeree named in 1(c), copy
table 3(a), (b), (c) or (d) (as appropriate) for each additional
class of relevant security dealt in.
The currency of all prices and other monetary amounts should be
stated.
(a) Purchases and sales
Class of relevant security Purchase/sale Number of securities Price per unit
12.5p ordinary Sale 6,700 124.86
--------------- --------------------- ---------------
(b) Cash-settled derivative transactions
Class of relevant Product description Nature of dealing Number of reference Price per unit
security e.g. CFD e.g. opening/closing a securities
long/short position,
increasing/reducing a
long/short position
n/a n/a n/a n/a n/a
-------------------- ------------------------- ------------------------- ---------------
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class of Product Writing, Number of Exercise Type Expiry date Option money
relevant description purchasing, securities price per e.g. paid/
security e.g. call selling, to which unit American, received per
option varying etc. option European unit
relates etc.
n/a n/a n/a n/a n/a n/a n/a n/a
------------- ------------- ------------- -------------- ------------- ------------ -------------
(ii) Exercise
Class of relevant Product description Exercising/ exercised Number of securities Exercise price per
security e.g. call option against unit
n/a n/a n/a n/a n/a
-------------------- ----------------------- --------------------- -----------------------
(d) Other dealings (including subscribing for new securities)
Class of relevant security Nature of dealing Details Price per unit (if applicable)
e.g. subscription, conversion
n/a n/a n/a n/a
------------------------------- -------- -------------------------------
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or understanding, formal
or informal, relating to relevant securities which may be an inducement to deal or refrain
from dealing entered into by the person making the disclosure and any party to the offer or
any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included. If there are no such
agreements, arrangements or understandings, state "none"
n/a
(b) Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal, between the person
making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which
any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"
n/a
(c) Attachments
Is a Supplemental Form 8 (Open Positions) attached? No
Please see attached reconciliation table for details on trades executed.
---
Date of disclosure: 07/03/2019
Contact name: Reece Cousins - Compliance Assistant
-------------------------------------
Telephone number: 020 3207 8177
-------------------------------------
Public disclosures under Rule 8 of the Code must be made to a
Regulatory Information Service.
The Panel's Market Surveillance Unit is available for
consultation in relation to the Code's disclosure requirements on
+44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at
www.thetakeoverpanel.org.uk.
Date Purchase/Sale Quantity traded Price per unit
(GBX)
25/01/2019 Sold 33,000 112.21
--------------- ---------------- ---------------
29/01/2019 Sold 2,719 116.17
--------------- ---------------- ---------------
01/02/2019 Sold 7,411 115.42
--------------- ---------------- ---------------
14/02/2019 Sold 9,125 115.36
--------------- ---------------- ---------------
15/02/2019 Sold 1,200 116.60
--------------- ---------------- ---------------
19/02/2019 Sold 27,125 118.05
--------------- ---------------- ---------------
25/02/2019 Sold 27,550 120.27
--------------- ---------------- ---------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
RETLLFFRVIIDIIA
(END) Dow Jones Newswires
March 07, 2019 11:23 ET (16:23 GMT)
Primary Health Properties (LSE:PHP)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Primary Health Properties (LSE:PHP)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024